USFDA conducts inspection at Alembic Pharma’s Karkhadi facility

08 Feb 2021 Evaluate

US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' New Injectable Facility (F-3) located at Karkhadi from January 29, 2021 to February 05, 2021. This was a scheduled inspection and at the end of the inspection, the USFDA issued a Form 483 with 5 observations.

None of the observations are related to data integrity and are procedural in nature. The Company is preparing the response to the observations, which will be submitted to USFDA shortly. The Company is committed to maintain highest quality standards that meet USFDA standards. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

 

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×